Colorectal carcinoma (CRC) is one of the most common causes of cancer-related mortality. Short-chain fatty acids secreted by dietary propionibacteria from the intestine, such as acetate, induce apoptosis in CRC cells and may therefore be relevant in CRC prevention and therapy. We previously reported that acetic acid-induced apoptosis in Saccharomyces cerevisiae cells involves partial vacuole permeabilization and release of Pep4p, the yeast cathepsin D (CatD), which has a protective role in this process. In cancer cells, lysosomes have emerged as key players in apoptosis through selective lysosomal membrane permeabilization (LMP) and release of cathepsins. However, the role of CatD in CRC survival is controversial and has not been assessed in response to acetate. We aimed to ascertain whether LMP and CatD are involved in acetate-induced apoptosis in CRC cells. We showed that acetate per se inhibits proliferation and induces apoptosis. More importantly, we uncovered that acetate triggers LMP and CatD release to the cytosol. Pepstatin A (a CatD inhibitor) but not E64d (a cathepsin B and L inhibitor) increased acetateinduced apoptosis of CRC cells, suggesting that CatD has a protective role in this process. Our data indicate that acetate induces LMP and subsequent release of CatD in CRC cells undergoing apoptosis, and suggest exploiting novel strategies using acetate as a prevention/therapeutic agent in CRC, through simultaneous treatment with CatD inhibitors.
Subject Category: Cancer
Colorectal carcinoma (CRC) is a leading cause of cancer death worldwide (GLOBOCAN 2008) , and thus finding new prevention and therapeutic approaches is of prime importance. Propionibacteria, found in fiber-rich food and dairy products, produce short-chain fatty acids (SCFA), mainly propionate and acetate, which induce apoptosis in CRC cells. Their potential in cancer prevention and therapy has thus been proposed by several authors [1] [2] [3] [4] [5] [6] and understanding the mechanisms underlying acetate-induced cell death should provide new prevention/therapeutic strategies in CRC.
The lysosomal pathway of apoptosis involves partial lysosomal membrane permeabilization (LMP), with subsequent release of proteases (such as cathepsins) into the cytosol. 7, 8 However, the role of this pathway in cancer is controversial. Transformation can lead to several lysosomal changes, such as increased lysosomal volume, secretion of proteases and total protease activity, 9 and changes in the subcellular localization of cathepsins B, D and L (CatB, CatD and CatL, respectively). 10 Such alterations become prooncogenic when enhanced secretion of cathepsins initiates proteolytic pathways that increase neoplastic progression. 11 Increased cysteine cathepsin activity is important for tumor angiogenesis, proliferation, growth and invasion. 12 Cathepsins are often overexpressed in human cancers, and high expression levels have been associated with increased risk of relapse and poor prognosis. 13 In contrast to their tumorpromoting effects, there is also evidence that they function as tumor suppressors.
14 This opposing role depends on the context: if cathepsins are released intracellularly they contribute to cancer cell death, but if released extracellularly they break down the extracellular matrix, stimulating angiogenesis and migration. 10 CatD is a lysosomal aspartyl protease involved in autophagy and apoptosis, thus having a crucial role in cell fate and tissue homeostasis. 15 CatD has emerged as a central player in the apoptotic response, although its role is cell-type and context-dependent. Expression patterns of CatD protein are divergent in CRC, suggesting a complex regulation and function of this protease, 16, 17 though its precise role remains poorly understood.
We previously showed that the vacuolar protease Pep4p, the Saccharomyces cerevisiae CatD, translocates to the cytosol during acetic acid-induced apoptosis, suggesting that the release of a vacuolar protease during regulated cell death is also conserved in yeast. 18 We additionally showed that Pep4p has a role in cell protection rather than in the execution of acetic acid-induced cell death. These results raised the possibility that partial LMP and consequent CatD release was involved in the response of CRC cells to acetate. Here, we show that CatD is released from lysosomes and might protect CRC cells from acetate-induced apoptosis. Our data therefore establish the lysosome and CatD as novel targets of acetate in CRC cells and indicate that CatD activity has important repercussions in the sensitivity of CRC to acetate produced in the intestine that might have prevention/therapeutic implications. The decrease in cell viability determined by MTT assay might be due to decreased cell proliferation, increased cell death or both. We therefore assessed cell proliferation after exposure to acetate using sulforhodamine B (SRB) and bromodeoxyuridine (BrdU) assays and apoptosis using Annexin V/propidium iodide (AV/PI), caspase activity and terminal deoxynucleotidyl transferase-mediated dUTP-fluorescein nick end labeling (TUNEL) assays, as well as sub-G1 population analysis by flow cytometry. The IC 50 of acetate reduced cell proliferation by approximately 30% and 65% in HCT-15 and RKO cells, respectively, as determined by SRB assay (Figure 1b) . In HCT-15 cells, IC 50 and 2 Â IC 50 of acetate reduced proliferation by approximately 17% and 75%, respectively, as determined by BrdU assay (Figures 1c and d) .
Results
We next analyzed cell death through AV/PI staining and found that acetate induced exposure of phosphatidylserine to the outer leaflet of the plasma membrane in HCT-15 cells in a dose-dependent manner (Figure 2a ). The number of cells stained with AV (AV þ PI À plus AV þ PI þ ) increased from 3.9% in the untreated control to 8.0, 18.2 and 47.9% after exposure to 70, 100 and 140 mM acetate, respectively, and to 49.1% when cells were exposed to etoposide for 48 h (Figure 2b ). Levels of necrotic cells (AV À PI þ ) after exposure to 70 or 100 mM acetate were very low. A higher dose of acetate (140 mM) increased the number of necrotic cells (B4% AV À /PI þ ), similarly to etoposide, although the majority of the population (B48%) was in early and late apoptosis (AV þ PI À plus AV þ PI þ ) (Figure 2b ). These results led us to conclude that acetate induces apoptosis rather than necrosis. Accordingly, caspase 3 was also activated in HCT-15 cells, as cleavage of the fluorogenic caspase 3 substrate z-DEVD-AMC, expressed in arbitrary fluorescence units/min/mg protein, increased from 3.6 in HCT-15 control cells (untreated) to 24.4 after exposure to 140 mM acetate (Figure 2c ). Similar results were obtained when activation of total caspases was assessed by labeling with the fluorescent pan-caspase inhibitor FICT-VAD-fmk (not shown). We also assessed the levels of DNA strand breaks in both the cell lines by TUNEL assay. In comparison to the negative control, there were no significant differences in the number of HCT-15 apoptotic cells after 48 h of treatment with 70 mM acetate (IC 50 ) (0.5% versus 1.6%; Figure 3a) , though phenotypic alterations typical of apoptosis (such as apoptotic bodies) were observed (Figure 3b) . However, the number of apoptotic cells increased significantly (7.2%) after 48 h of treatment with 140 mM acetate (2 Â IC 50 ) (Figure 3a) . Exposure to 110 mM acetate (IC 50 ) induced a minor increase in the number of apoptotic RKO cells, compared with low basal apoptotic levels (1.6% versus 0.3%; Figure 3a ), but again with evident phenotypic alterations (Figure 3b ). When treated with 220 mM acetate (2 Â IC 50 ), the number of apoptotic RKO cells increased significantly (65.5%; Figure 3a ). Acetate also led to a dose-dependent increase in the sub-G1 peak of HCT-15 cells, indicative of an apoptotic sub-population, and similar to that of cells treated with etoposide ( Figure 5b ). Two peaks corresponding to the G1 and G2/M phases of the cell cycle were evident in DNA content histograms of HCT-15 control (untreated) cells, with very few cells in the hypodiploid sub-G1 cell-cycle phase (2% of the total events acquired). Exposure to etoposide or 140 mM acetate greatly increased the percentage of hypodiploid cells to approximately 70% and 35%, respectively (Figure 5b ).
It has been reported that the pH influences the cell death pathway induced by SCFA produced by propionibacteria, that is, SCFA trigger apoptosis at pH 7.5 in HT-29 cells but necrosis at pH 5.5. 1 In our study, the pH of the culture medium after 48 h of incubation with acetate was closer to 7.5 than to 5.5 in both HCT-15 and RKO cell lines and was similar to that of the control culture (Table 1) . In RKO cells, the pH of the control culture medium (pH ¼ 8.00) was higher than that of HCT-15 cells (pH ¼ 7.45), probably due to the different composition of the growth medium (DMEM (Dulbecco's Modified Eagle's Medium) for RKO cells and RPMI for HCT-15 cells) and to the different growth rates of these cell lines. Taken together, our results show that, under our experimental conditions, acetate induced apoptosis.
Acetate induces lysosomal permeabilization and cathepsin D release to the cytosol. We next investigated whether the lysosomal pathway was involved in acetateinduced apoptosis in CRC cells. We measured LMP both by staining with the lysosomotropic agent Acridine Orange (AO) and by immunoblot detection of CatD in cytosolic fractions. AO is a weak base that moves freely across membranes when uncharged and accumulates in acidic compartments like lysosomes in its protonated form, where it forms aggregates that fluoresce bright red. LMP is associated with proton release, which renders lysosomes more alkaline and hence with decreased red fluorescence. LMP was monitored qualitatively by fluorescence microscopy and quantitatively by flow cytometry, by measuring the percentage of cells with loss of lysosomal AO red fluorescence. Etoposide was used as a positive control, as it destabilizes lysosomes and induces LMP through CatD release to the cytosol. As lysosomal proteases such as CatD are released from lysosomes to the cytosol after LMP, their detection in the cytosolic fraction is indicative of LMP. We therefore treated HCT-15 and RKO CRC cells with two concentrations of acetate (IC 50 and 2 Â IC 50 for each cell line), or with etoposide, and detected CatD in whole-cell extracts and in cytosolic fractions by western blot (Figure 4d ). We found that CatD is expressed in whole-cell lysates and that untreated cells exhibited very low levels of CatD in the cytosol. Notably, we found that exposure to etoposide and to IC 50 and 2 Â IC 50 concentrations of acetate led to CatD release to the cytosol, indicating that acetate induces LMP in a concentration-dependent manner and further suggesting that acetate induces a lysosomal pathway of apoptosis in both the cell lines. We also observed that exposure to acetate Figure 5a ). PstA-treated HCT-15 cells exposed to acetate also exhibited a higher percentage of cells with sub-G1 DNA content than cells treated with acetate alone, indicative of higher apoptotic levels (Figures 5b and c) . By contrast, inhibition of CatD in cells exposed to etoposide decreased the sub-G1 population (Figures 5b and c) , in agreement with previous reports showing that CatD has a pro-apoptotic role in etoposide-induced cell death. 21 These results therefore indicate that CatD has a protective role in acetate-induced apoptosis in CRC cells, as has been observed in S. cerevisiae cells for Pep4p, the human CatD ortholog. 
Discussion
CRC is a leading cause of mortality in Europe, and its global therapeutics market is worth billions of Euros (GLOBOCAN). Worldwide variations in colorectal cancer incidence suggest that dietary and lifestyle factors contribute to its etiology and are important risk factors for CRC. CRC is most susceptible to dietary influence, and a higher intake of dietary fibers can reduce the risk of CRC. 22 SCFA, particularly propionate and acetate, are the end products of fermentation of physiological bacteria, namely propionibacteria, which are present in dietary fibers and several dairy products frequently consumed. 23 Both Figure 5 CatD has a protective role in acetate-induced apoptosis. Effect of the specific CatD inhibitor (PstA) and CatB and CatL inhibitor (E64d) on apoptosis in HCT-15 and RKO cells treated with acetate. PstA (100 mM) was pre-incubated for 16 h and then co-incubated with acetate for 48 h. E64d (10 mM) was pre-incubated for 1 h and then co-incubated with acetate for 48 h. pure SCFA and propionibacteria culture supernatants from the dairy species Propionibacterium freudenreichii and Propionibacterium acidipropionici induce apoptosis in CRC cells in vitro. [1] [2] [3] Moreover, administration of P. freudenreichii in vivo significantly increased the number of apoptotic epithelial cells damaged by 1,2-dimethylhydrazine, a carcinogenic agent, without affecting the survival of healthy normal colonic mucosa. 4, 5 These characteristics indicate that propionibacteria might have a protective role against colon cancer, acting as a probiotic, and point to a useful role of propionibacteria and their metabolites propionate, butyrate and acetate as powerful agents for CRC prevention or therapy.
We showed that acetate per se induces apoptosis in CRC-derived cell lines HCT-15 and RKO, by inducing DNA fragmentation, caspase activation, phosphatidylserine exposure to the outer leaflet of the plasma membrane and the appearance of a sub-G1 population. The concentrations used in our study were in the physiological range; total SCFA concentrations from 50-200 mM have been reported in the intestinal lumen of a wide range of vertebrates and in most cases remain at constant high levels throughout the bowel length. 24, 25 Our results are thus in agreement with previous reports showing that propionibacteria supernatants, as well as pure acetate and/or propionate, induce apoptosis in HT-29 and CACO-2 CRC cell lines. 3 In these cells, a mixture of acetate and propionate induced caspase 3 activation, nuclei shrinkage, chromatin condensation and nuclei fragmentation into apoptotic bodies. It was also demonstrated that mitochondria have a critical role in this process, evidenced by increased mitochondrial outer membrane permeability and enhanced reactive oxygen species accumulation in response to acetate and propionate, alone or in combination. 3 These authors also identified the mitochondrial adenine nucleotide translocator (ANT) as a potential SCFA target, suggesting that mitochondria and ANT are involved in the cell death pathway. 3 The cell microenvironment may be a determinant for the type of cell death induced by toxic stimuli. The pH of the human colon lumen ranges from 5.5-7.5. SCFA produced by P. freudenreichii trigger apoptosis in HT-29 cells at pH 7.5 but necrosis at pH 5.5. At pH 7.5, propionibacterial SCFA were shown to induce cell-cycle arrest in the G2/M phase and morphological characteristics of apoptotic cell death, like membrane blebbing, chromatin condensation and fragmentation, phosphatidylserine exposure and formation of apoptotic bodies. 1 In accordance with these reports, we showed that acetate induces apoptosis in HCT-15 and RKO cells without altering the extracellular pH (complete medium). We also demonstrated that acetate alone inhibits proliferation in both the cell lines, in agreement with previous reports. 1 We have previously demonstrated in the yeast S. cerevisiae that acetic acid induces a mitochondria-mediated apoptotic process 18 with several features similar to apoptosis induced by SCFA in CRC cells. Notably, the mitochondrial inner membrane AAC carrier, the yeast ortholog of mammalian ANT, was required for mitochondrial outer membrane permeabilization and cytochrome c release in yeast cells committed to apoptosis induced by acetic acid. We also observed that Pep4p, the yeast CatD, was released from the lysosome-like vacuole to the cytosol in response to acetic acid. 18 As acetic acid and acetate trigger apoptosis through an analogous pathway in both yeast and CRC cells, respectively, we hypothesized that partial LMP with CatD release might also be involved in acetate-induced apoptosis in CRC cells. The involvement of lysosomes in apoptotic cell death, mainly through partial LMP, has gained increased attention. 7 It is now established that they are important contributors to cancer cell death, increasing interest in exploiting lysosomal cell death pathways as a potential target in cancer therapy. 10 LMP followed by release of lysosomal contents to the cytosol, especially cathepsins, seems to be the critical step of the lysosomal death pathway. The most relevant human cathepsins are the proteases CatB and CatL and the sole lysosomal aspartic protease CatD. They are most abundant in the lysosome 26 and remain active at a neutral pH. 27 Overexpression of cathepsins often occurs in human cancers, and high levels of their expression can be associated with increased risk of relapse and poor prognosis. 13 However, besides the tumor-promoting effects of these proteases, there is evidence that cathepsins may also function as tumor suppressors. 14 Little is known about the role of the lysosomal pathway in cell death regulation in CRC. It has been shown that resveratrol, a naturally occurring polyphenol, triggers a caspase-dependent intrinsic pathway of apoptosis involving lysosomal CatD in CRC cells. The authors provide evidence that CatD, though not CatB or CatL, mediates resveratrol cytotoxicity in DLD1 and HT29 cell lines, inducing lysosome leakage with increased cytosolic CatD. 28 In this study, we aimed to investigate the mechanisms underlying acetateinduced apoptosis in CRC cells, focusing on the role of the lysosomal pathway through LMP and CatD release. We showed, for the first time, by different approaches that exposure of CRC cells to acetate leads to LMP, release of CatD to the cytosol and accumulation of Pro-CatD and mature CatD. We also showed that inhibiting CatD with PstA, a widely used specific inhibitor of CatD enzymatic activity, 21, [28] [29] [30] [31] [32] [33] increased acetate-induced apoptosis in CRC cells. Interestingly, in yeast, deletion of Pep4p confers higher susceptibility to acetic acid, while cells overexpressing Pep4p display higher resistance. 18 Recently, it has also been demonstrated that Pep4p has a dual cytoprotective function, anti-apoptotic Acetate induces CatD release in CRC cells C Marques et al and anti-necrotic, during S. cerevisiae chronological aging via the polyamine pathway. 34 Our data in CRC cells are thus in agreement with the results obtained in yeast. Taken together, our results point to a function of CatD in cell protection rather than in the execution of acetate-induced cell death, in both CRC and yeast.
The role of CatD expression in colon carcinogenesis is controversial and poorly understood. CatD protein levels in CRC clinical cases show divergent expression patterns, suggesting a complex regulation and function of this protease. 17, 28, [35] [36] [37] [38] [39] [40] [41] One study showed that the average CatD protein content was not different in 59 CRC when compared with normal mucosa, but individual tumors demonstrated marked changes in CatD expression levels. 16 Measurement of protein content of tumor versus normal pairs on western blots revealed loss of CatD in 450% of CRC. However, two-fold increases in CatD protein levels were also observed in B1/3 of tumors, supporting the concept that CRC develop via divergent molecular pathways and that CatD may function differently in different cancers. 16 Another study analyzed surgical specimens of 100 primary CRC with different grades of differentiation and determined that immunoreactivity for CatD was negative in the cytoplasm of normal colorectal epithelial cells adjacent to carcinoma. CatD expression in carcinoma cells was present in 68% of the cases, and CatD positivity was higher when the grade of differentiation was higher. 17 Yet another study showed that the majority of CRC (93/106) stained positive for CatD, whereas normal colon was almost completely negative. 35 It is therefore apparent that some, but not all, CRC cells overexpress CatD in comparison to normal colon mucosa.
In the present study, we showed that CRC cell lines HCT-15 and RKO express CatD and are sensitive to physiological levels of acetate, suggesting that the levels of CatD observed might differ from those of normal colon cells. However, we could not test this hypothesis 'in vitro' because the only available 'normal' human colon mucosal epithelium-derived cells NCM460 (INCELL Corporation, San Antonio, TX, USA) 42 also express CatD and behave similarly to RKO cells in response to acetate (data not shown). According to information provided by INCELL, NCM460 cells have acquired a tumorigenic phenotype due to their extended time in culture.
The protective role of CatD demonstrated by our data might partly explain why CatD is overexpressed in some CRC clinical cases in comparison to normal colon mucosa. We therefore hypothesize that increased expression of this protease might be beneficial to cancer cells and thus that CatD might have an 'oncogenic-like effect', allowing CRC cells to survive in the presence of physiological levels of SCFA in the colon.
In summary, our novel findings show that acetate induces partial LMP and consequent release of CatD to the cytosol in CRC cells. Our results also indicate that inhibition of CatD enzymatic activity sensitizes CRC cells to acetate-induced apoptosis, suggesting that CatD, like Pep4p in yeast, might have a protective role in this process. However, the mechanism involved remains elusive and will warrant further investigation. Our observations indicate that CatD protects cells from acetate exposure, prompting further exploiting the differential sensitivity of CRC to acetate. Inhibiting CatD function therefore emerges as a novel prevention/ therapeutic strategy in CRCs, particularly in the case of CRCs with decreased levels of CatD. Specifically increasing the sensitivity of CatD-overexpressing CRCs without affecting normal colon mucosa cells will likely require nanodelivery systems of CatD inhibitors such as PstA to specifically target CRC cells, in combination with strategies to increase acetate concentrations in the colon, namely emerging nutraceuticals.
Materials and Methods
Cell lines and culture conditions. HCT-15 and RKO cell lines derived from human CRC were maintained at 37 1C under a humidified atmosphere containing 5% CO 2 . HCT-15 cells were grown in RPMI medium with L-glutamine and HEPES supplemented with 10% heat inactivated fetal bovine serum, 100 U/ml penicillin/streptomycin. RKO cells were grown in DMEM supplemented with 1 mM sodium pyruvate, 1.5 g/l sodium bicarbonate, 10% fetal bovine serum, 100 U/ml penicillin/streptomycin. Cells were seeded and adhered onto appropriate sterile plates for 24 h before treatments.
Assessment of cell viability by MTT reduction assay. Cells were incubated with different concentrations of sodium acetate, henceforth referred to as acetate, for 48 h. Freshly prepared MTT was added at a final concentration of 0.5 mg/ml in PBS pH 7.4 and plates incubated in the dark for 2 h at 37 1C. In all, 500 ml of acidic isopropanol (0.04 M HCl in absolute isopropanol) were added to each well, followed by 30 min of orbital shaking in the dark, to solubilize the formazan crystals. Absorbance was read at 570 nm in a microplate reader (SpectraMax 340PC, Molecular Devices, Sunnyvale, CA, USA). Results were expressed as a percentage of sample absorbance in relation to the negative control (untreated cells).
Cell proliferation assays SRB: Cells were incubated with different acetate concentrations for 48 h, fixed in ice-cold methanol containing 1% acetic acid, and incubated with 0.5% (w/v) SRB dissolved in 1% acetic acid for 1.5 h at 37 1C. After washing with 1% acetic acid, SRB was solubilized with 10 mM Tris, pH 10. Absorbance was read at 540 nm in a microplate reader (SpectraMax 340PC Molecular Devices). Results were expressed relatively to the negative control (untreated cells), which was considered as 100% of cell proliferation.
BrdU incorporation: Cells were seeded in plates containing glass coverslips, exposed to acetate for 48 h and incubated with 10 mM BrdU for 1 h. Cells were fixed with 4% paraformaldehyde and nuclear incorporation of BrdU was detected by immunofluorescence. Coverslips were mounted on Vectashield Mounting Medium with DAPI (4',6-diamidino-2-phenylindole) and the percentage of positive nuclei (BrdU index) was determined from 4500 cells/datum point.
Apoptosis assays TUNEL: Cells were exposed to DMSO control, etoposide or different concentrations of acetate for 48 h. When cathepsin inhibitors were used, cells were preincubated with PstA or E64d for 16 h and 1 h, respectively, and then co-incubated with acetate or etoposide for 48 h. Cytospins of both floating and attached cells were fixed with 4% paraformaldehyde for 15 min at room temperature (RT). Cells were washed in PBS and permeabilized with ice-cold 0.1% Triton X-100 in 0.1% sodium citrate. TUNEL was performed following the manufacturer's instructions ('In situ cell death detection kit, fluorescein', Roche, Mannheim, Germany). Slides were mounted on Vectashield Mounting Medium with DAPI and maintained at À 20 1C until visualization in a fluorescence microscope (Leica DM 5000B, Leica Microsystems, Wetzlar, Germany).
Caspase 3 activity: Cells were exposed to etoposide or acetate for 48 h. Both floating cells and attached cells were collected, washed twice with PBS, and lysed in Lysis Buffer (10 mM Tris, pH 7.5, 0.1 M NaCl, 1 mM EDTA, 0.01% Triton X-100) through three freeze/thaw cycles. In all, 50 ml of total extracts (1 mg/ml) were incubated with 50 ml 200 mM z-DEVD-AFC (Biomol, Plymouth Meeting, PA, USA) in 2 Â reaction buffer (20 mM PIPES, pH 7.4, 4 mM EDTA, 10 mM DTT) and fluorescence of cleaved AFC was measured using a fluorescence microplate reader (Fluoroskan Ascent FL, Thermo Fisher Scientific Inc., Waltham, MA, USA).
AV/PI staining: Cells were treated with etoposide or acetate for 48 h. Both floating and attached cells were collected and washed in PBS. In all, 1 Â 10 6 cells were resuspended in 200 ml 1 Â binding buffer and incubated with 8 ml AV-fluorescein isothiocyanate (BD Biosciences, San Jose, CA, USA) and 15 ml 50 mg/ml PI for 15 min in the dark. Samples were analyzed in a flow cytometer (Epics XL, Beckman Coulter, Miami, FL, USA) equipped with an argon-ion laser emitting a 488-nm beam at 15 mW. Monoparametric detection of red fluorescence was performed using FL-3 (488/620 nm) and detection of green fluorescence was performed using FL-1 (488/ 525 nm). In all, 20 000 cells were analyzed per sample and data analyzed using FlowJo software (version 7.6, Tree Star Inc., Ashland, OR, USA).
Sub-G1 cell population analysis: Cells were treated with DMSO, etoposide or acetate for 48 h. When PstA was used, cells were pre-incubated as described above. Both floating and attached cells were collected, washed with PBS and incubated with 70% cold ethanol for 15 min. Cells were then washed twice with PBS, incubated with RNase A (200 mg/ml) for 15 min in the dark at 37 1C and with propidium iodide (0.5 mg/ml) for 30 min at RT before analysis on a flow cytometer, as described above. FlowJo software was used to generate DNA content frequency histograms and quantify the amount of cells in the individual cell-cycle phases, including the sub-G1 population assumed as corresponding to apoptotic cells.
LMP assessment AO staining analysis by fluorescence microscopy: Cells were seeded in six-well plates containing glass coverslips, and exposed to etoposide or acetate for 48 h. Cells were then incubated with 1 mM AO for 15 min at 37 1C and washed with PBS. Coverslips were mounted over glass slides with PBS and immediately observed and photographed using a fluorescence microscope (Leica DM 5000B).
AO staining analysis by flow cytometry: Cells were exposed to etoposide or acetate for 48 h. Both floating and attached cells were collected, washed with PBS and resuspended in PBS to a final concentration of 1 Â 10 6 cells in 1.5 ml. Cells were then incubated with 1 mM AO (or without AO to measure autofluorescence) for 15 min at 37 1C.
